Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.58 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.35.
Market Cap
9.58T
Revenue
4.66T
Profits
186.48B
PE Ratio
51.35
Profit Margin
4.00%
Dividend Yield
0.37%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | -1.38% | 451,922 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 654.41B | 0.48% | 1,327,523 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.93B | -0.70% | 695,366 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 369.29B | -1.88% | 3,186,399 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 353.96B | 1.08% | 1,098,894 | 450.53B |
| 6 | NVS | Novartis AG | 302.17B | -0.59% | 306,028 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 258.76B | -0.69% | 741,273 | 61.37B |
| 8 | AMGN | Amgen Inc. | 238.04B | 0.22% | 339,680 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 229.33B | -1.43% | 420,488 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 207.84B | 0.15% | 2,761,049 | 50.34B |
| 11 | ABT | Abbott Laboratories | 202.16B | 0.16% | 1,183,996 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 180.17B | -0.56% | 876,117 | 30.46B |
| 13 | PFE | Pfizer Inc. | 158.91B | -0.68% | 6,340,501 | 63.70B |
| 14 | DHR | Danaher Corporation | 152.20B | -1.07% | 388,254 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.80B | -0.08% | 135,329 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.19B | -0.51% | 1,701,219 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 133.42B | -0.30% | 337,633 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.92B | 0.44% | 291,369 | 25.84B |
| 19 | MDT | Medtronic plc | 119.52B | 0.03% | 962,996 | 36.36B |
| 20 | CVS | CVS Health Corporation | 118.51B | -0.39% | 998,649 | 412.65B |
| 21 | SNY | Sanofi | 110.41B | -0.44% | 621,237 | 55.89B |
| 22 | GSK | GSK plc | 104.78B | -1.09% | 903,333 | 44.05B |
| 23 | MCK | McKesson Corporation | 101.37B | 1.23% | 120,137 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 93.64B | 0.77% | 362,987 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.81B | -0.06% | 131,832 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.26B | -1.23% | 87,861 | 15.53B |
| 27 | CI | The Cigna Group | 73.52B | 0.26% | 162,333 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.60B | -1.92% | 3,159,217 | 21.00B |
| 29 | ARGX | argenx SE | 65.85B | -3.55% | 153,372 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.32B | 1.04% | 216,233 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.23B | 0.17% | 1,085,937 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 53.96B | -6.86% | 14,869,042 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 53.38B | - | 199,811 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 52.26B | -0.07% | 481,993 | 22.48B |
| 35 | EW | Edwards Lifesciences Corporation | 52.14B | 0.74% | 486,435 | 6.51B |
| 36 | NTRA | Natera, Inc. | 47.21B | -1.36% | 270,326 | 2.71B |
| 37 | HUM | Humana Inc. | 46.31B | 1.78% | 228,720 | 145.68B |
| 38 | MDLN | Medline Inc. | 45.94B | 1.98% | 1,203,398 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.37B | -1.18% | 371,397 | - |
| 40 | IDXX | IDEXX Laboratories, Inc. | 43.87B | -0.01% | 65,860 | 4.55B |
| 41 | A | Agilent Technologies, Inc. | 43.64B | -2.81% | 840,562 | 7.23B |
| 42 | HLN | Haleon plc | 43.60B | 1.45% | 7,925,348 | 14.80B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 42.99B | -1.21% | 725,675 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 42.76B | -0.01% | 201,265 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.01B | -1.33% | 58,844 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 40.30B | 0.09% | 449,689 | 3.32B |
| 47 | WAT | Waters Corporation | 40.05B | -0.74% | 101,085 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.46B | -0.14% | 241,816 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.18B | -0.21% | 451,709 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.92B | 0.21% | 533,949 | 4.97B |
| 51 | RMD | ResMed Inc. | 33.56B | 0.49% | 245,744 | 5.65B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 33.54B | -0.74% | 533,073 | 21.27B |
| 53 | ILMN | Illumina, Inc. | 32.91B | -0.67% | 397,990 | 4.49B |
| 54 | CNC | Centene Corporation | 32.25B | 0.40% | 539,880 | 180.30B |
| 55 | ZTS | Zoetis Inc. | 31.92B | -0.62% | 796,535 | 9.53B |
| 56 | BIIB | Biogen Inc. | 31.68B | -1.11% | 132,436 | 10.03B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.20B | -1.30% | 686,823 | 4.80B |
| 58 | BNTX | BioNTech SE | 28.12B | -3.98% | 691,460 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.06B | 0.36% | 46,983 | 4.13B |
| 60 | INSM | Insmed Incorporated | 27.38B | -0.32% | 282,279 | 1.14B |
| 61 | LH | Labcorp Holdings Inc. | 27.34B | 0.22% | 71,257 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.95B | -0.10% | 152,654 | 11.56B |
| 63 | PHG | Koninklijke Philips N.V. | 26.94B | 0.51% | 177,080 | 20.18B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.23B | 0.03% | 1,263,642 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.89B | -0.08% | 129,626 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.66B | -0.76% | 73,045 | 3.33B |
| 67 | STE | STERIS plc | 23.18B | -0.09% | 57,425 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 22.49B | -0.54% | 113,966 | 21.81B |
| 69 | GH | Guardant Health, Inc. | 22.03B | -3.84% | 719,260 | 1.18B |
| 70 | UTHR | United Therapeutics Corporation | 21.98B | -0.14% | 72,268 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.06B | -1.18% | 1,284,486 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.32B | 0.33% | 238,073 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.78B | 0.18% | 660,024 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.26B | -0.38% | 27,957 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.50B | -0.78% | 99,492 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.33B | -1.09% | 44,528 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.70B | -1.48% | 227,919 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.51B | 0.01% | 239,466 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.36B | 0.76% | 116,464 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.82B | -0.29% | 161,030 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.08B | -0.12% | 137,373 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.63B | -2.08% | 489,810 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.55B | -0.49% | 563,639 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.44B | 0.28% | 291,582 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.20B | -0.63% | 58,367 | 8.29B |
| 86 | CORT | Corcept Therapeutics Incorporated | 13.10B | -0.91% | 121,482 | 830.81M |
| 87 | PEN | Penumbra, Inc. | 12.76B | -0.36% | 10,654 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.70B | -1.63% | 292,746 | 3.41B |
| 89 | FMS | Fresenius Medical Care AG | 12.42B | 0.21% | 135,983 | 22.19B |
| 90 | TEM | Tempus AI, Inc. | 12.28B | -6.36% | 5,386,973 | 1.43B |
| 91 | SNN | Smith & Nephew plc | 12.26B | 1.44% | 277,136 | 6.30B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.25B | -0.15% | 351,708 | 14.37B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.23B | -0.35% | 206,265 | 1.66B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.22B | -0.67% | 185,287 | 669.50M |
| 95 | ELAN | Elanco Animal Health Incorporated | 12.07B | 0.75% | 891,039 | 5.02B |
| 96 | EHC | Encompass Health Corporation | 12.01B | 1.18% | 183,874 | 6.21B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | -1.54% | 24,617 | 1.28B |
| 98 | GMED | Globus Medical, Inc. | 11.51B | -1.38% | 200,228 | 3.14B |
| 99 | ALGN | Align Technology, Inc. | 11.46B | -0.74% | 201,865 | 4.14B |
| 100 | TECH | Bio-Techne Corporation | 11.34B | 0.03% | 584,818 | 1.22B |
| 101 | ABVX | ABIVAX Société Anonyme | 11.12B | -0.28% | 457,641 | 5.67M |
| 102 | DVA | DaVita Inc. | 11.08B | -0.02% | 120,932 | 14.01B |
| 103 | GKOS | Glaukos Corporation | 10.86B | -0.36% | 137,321 | 612.84M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.83B | -0.50% | 51,236 | 776.57M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.73B | 0.44% | 419,131 | 67.67M |
| 106 | MOH | Molina Healthcare, Inc. | 10.44B | 0.04% | 79,435 | 42.47B |
| 107 | ENSG | The Ensign Group, Inc. | 10.44B | 0.62% | 92,056 | 5.49B |
| 108 | UHS | Universal Health Services, Inc. | 10.42B | -0.24% | 82,117 | 18.11B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.40B | 0.33% | 373,283 | 3.50B |
| 110 | PRAX | Praxis Precision Medicines, Inc. | 10.29B | -1.99% | 88,320 | 7.46M |
| 111 | RGEN | Repligen Corporation | 10.25B | 0.28% | 231,248 | 785.10M |
| 112 | PODD | Insulet Corporation | 10.22B | -0.53% | 308,411 | 3.05B |
| 113 | APGE | Apogee Therapeutics, Inc. | 10.16B | 0.01% | 184,807 | - |
| 114 | IONS | Ionis Pharmaceuticals, Inc. | 10.14B | 2.18% | 541,842 | 874.09M |
| 115 | KRYS | Krystal Biotech, Inc. | 10.14B | -1.19% | 58,396 | 440.48M |
| 116 | OSCR | Oscar Health, Inc. | 10.13B | 2.59% | 1,594,848 | 15.32B |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 10.05B | -1.09% | 39,236 | 2.59B |
| 118 | SMMT | Summit Therapeutics Inc. | 9.93B | -5.40% | 1,319,125 | - |
| 119 | HSIC | Henry Schein, Inc. | 9.90B | 0.34% | 53,244 | 13.60B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.86B | -1.23% | 62,067 | 281.99M |
| 121 | KYMR | Kymera Therapeutics, Inc. | 9.85B | -1.14% | 95,707 | 105.00M |
| 122 | AVTR | Avantor, Inc. | 9.62B | -1.66% | 908,761 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.37B | -0.22% | 255,816 | - |
| 124 | PCVX | Vaxcyte, Inc. | 9.21B | -1.11% | 129,222 | - |
| 125 | IMVT | Immunovant, Inc. | 9.04B | -1.35% | 333,268 | - |
| 126 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.11% | 269,271 | 42.16M |
| 127 | HQY | HealthEquity, Inc. | 8.84B | 0.27% | 87,514 | 1.34B |
| 128 | QGEN | Qiagen N.V. | 8.83B | -3.13% | 3,344,253 | 2.10B |
| 129 | BRKR | Bruker Corporation | 8.82B | -2.84% | 173,530 | 3.50B |
| 130 | TWST | Twist Bioscience Corporation | 8.81B | -3.48% | 411,831 | 431.80M |
| 131 | ATR | AptarGroup, Inc. | 8.65B | 0.91% | 60,028 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.26B | -2.67% | 813,497 | 616.91M |
| 133 | ALKS | Alkermes plc | 8.09B | -0.27% | 177,536 | 1.67B |
| 134 | IBRX | ImmunityBio, Inc. | 8.03B | -2.70% | 2,596,240 | 165.79M |
| 135 | TGTX | TG Therapeutics, Inc. | 7.69B | -0.06% | 611,475 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.69B | 1.51% | 127,555 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.43B | 0.11% | 2,590,342 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.36B | 3.20% | 1,158,844 | 720.06M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.24B | -8.17% | 5,679,685 | 2.58B |
| 140 | CHE | Chemed Corporation | 7.05B | 0.26% | 25,165 | 2.60B |
| 141 | CGON | CG Oncology, Inc. | 7.03B | -0.61% | 136,225 | 6.23M |
| 142 | PACS | PACS Group, Inc. | 7.03B | 0.32% | 69,211 | 5.55B |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.97B | 1.31% | 275,816 | - |
| 144 | GRFS | Grifols, S.A. | 6.97B | 0.06% | 91,749 | 8.48B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.76B | -5.43% | 321,811 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.31% | 174,336 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.43B | -0.94% | 34,563 | - |
| 148 | COGT | Cogent Biosciences, Inc. | 6.33B | -0.76% | 316,331 | - |
| 149 | STVN | Stevanato Group S.p.A. | 6.28B | 1.75% | 50,731 | 1.40B |
| 150 | LQDA | Liquidia Corporation | 6.28B | 2.19% | 241,764 | 450.91M |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.34% | 60,596 | 618.07M |
| 152 | BLCO | Bausch + Lomb Corporation | 6.20B | 0.64% | 62,091 | 5.32B |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.15B | -0.20% | 73,912 | 840.85M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.15B | -1.07% | 147,344 | 1.90M |
| 155 | TVTX | Travere Therapeutics, Inc. | 6.09B | -1.64% | 234,207 | 591.33M |
| 156 | ERAS | Erasca, Inc. | 6.09B | -1.30% | 627,262 | - |
| 157 | RDNT | RadNet, Inc. | 5.94B | -1.72% | 78,149 | 2.27B |
| 158 | TFX | Teleflex Incorporated | 5.88B | -0.01% | 87,338 | 2.25B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.87B | -0.28% | 203,554 | 7.50M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.81B | -0.21% | 167,496 | 1.01B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.81B | -3.79% | 752,203 | - |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.70B | -0.39% | 276,129 | 3.12B |
| 163 | MMED | MiniMed Group, Inc. | 5.64B | -1.81% | 159,003 | 3.10B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.64B | -1.22% | 40,272 | 290.54M |
| 165 | CRSP | CRISPR Therapeutics AG | 5.52B | -3.98% | 473,615 | 13.39M |
| 166 | SHC | Sotera Health Company | 5.47B | -1.99% | 278,769 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.43B | 0.10% | 50,211 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.09B | 0.14% | 189,726 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.94B | -0.20% | 139,876 | 1.35B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.82B | -1.07% | 367,063 | - |
| 171 | WAY | Waystar Holding Corp. | 4.82B | 0.52% | 252,093 | 1.21B |
| 172 | PBLS | Parabilis Medicines, Inc. | 4.80B | -1.30% | 77,849 | 148.00K |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.79B | -0.11% | 273,917 | - |
| 174 | LFST | LifeStance Health Group, Inc. | 4.77B | 0.16% | 610,387 | 1.58B |
| 175 | DOCS | Doximity, Inc. | 4.60B | 1.93% | 559,701 | 655.57M |
| 176 | ICUI | ICU Medical, Inc. | 4.55B | -0.47% | 27,518 | 2.16B |
| 177 | CELC | Celcuity Inc. | 4.51B | -1.51% | 95,680 | - |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.50B | 0.87% | 45,987 | 2.29B |
| 179 | BLLN | BillionToOne, Inc. | 4.49B | 0.18% | 107,560 | 397.41M |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.43B | 1.05% | 506,201 | - |
| 181 | NVST | Envista Holdings Corporation | 4.37B | 0.04% | 254,801 | 2.86B |
| 182 | HTFL | HeartFlow, Inc. | 4.34B | 0.30% | 579,945 | 212.07M |
| 183 | LIVN | LivaNova PLC | 4.33B | -0.27% | 69,940 | 1.47B |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.31B | -0.91% | 159,628 | 1.33B |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.26B | 0.08% | 767,739 | 10.35M |
| 186 | ITGR | Integer Holdings Corporation | 4.26B | 0.04% | 90,211 | 1.84B |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.22B | -0.41% | 48,723 | 825.34M |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.21B | -2.30% | 690,485 | -665.00K |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 4.09B | -1.42% | 338,255 | 308.08M |
| 190 | LEGN | Legend Biotech Corporation | 4.04B | -4.35% | 579,363 | 1.27B |
| 191 | MANE | Veradermics, Incorporated | 3.98B | -7.42% | 259,171 | - |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.95B | -1.88% | 398,348 | 53.81M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.94B | 3.44% | 108,066 | 890.79M |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.87B | 0.07% | 344,565 | 117.00M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | 0.92% | 121,995 | 234.13M |
| 196 | VKTX | Viking Therapeutics, Inc. | 3.85B | -2.51% | 379,232 | - |
| 197 | DNLI | Denali Therapeutics Inc. | 3.84B | -3.61% | 484,208 | 3.60M |
| 198 | IOVA | Iovance Biotherapeutics, Inc. | 3.69B | -1.63% | 6,650,655 | 324.97M |
| 199 | NHC | National HealthCare Corporation | 3.65B | -0.04% | 16,055 | 1.56B |
| 200 | OGN | Organon & Co. | 3.60B | -0.18% | 1,936,536 | 6.13B |
| 201 | OPCH | Option Care Health, Inc. | 3.58B | 0.84% | 120,440 | 5.69B |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.53B | -1.88% | 105,371 | 1.19M |
| 203 | ABCL | AbCellera Biologics Inc. | 3.47B | -5.48% | 3,176,550 | 66.17M |
| 204 | GPCR | Structure Therapeutics Inc. | 3.44B | -1.61% | 120,707 | - |
| 205 | GRAL | GRAIL, Inc. | 3.42B | -3.68% | 117,621 | 165.26M |
| 206 | VCYT | Veracyte, Inc. | 3.31B | -2.62% | 93,221 | 561.90M |
| 207 | WRBY | Warby Parker Inc. | 3.31B | -2.37% | 367,857 | 911.61M |
| 208 | QURE | uniQure N.V. | 3.27B | -2.48% | 172,629 | 18.67M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | -3.07% | 335,082 | 7.12M |
| 210 | MBX | MBX Biosciences, Inc. | 3.22B | 0.66% | 141,013 | - |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.21B | 1.39% | 120,271 | 158.00K |
| 212 | IMNM | Immunome, Inc. | 3.21B | -0.84% | 97,645 | 4.02M |
| 213 | TMDX | TransMedics Group, Inc. | 3.21B | -2.35% | 185,354 | 668.47M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.18B | -0.27% | 78,278 | 606.33M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -0.04% | 257,113 | 463.98M |
| 216 | IRON | Disc Medicine, Inc. | 3.12B | 1.89% | 65,516 | - |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 3.03B | 5.40% | 1,238,044 | 2.60B |
| 218 | ALMS | Alumis Inc. | 2.96B | -5.54% | 127,948 | 7.40M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.87B | 1.95% | 1,192,908 | 2.93B |
| 220 | ZLAB | Zai Lab Limited | 2.87B | -1.88% | 512,613 | 449.61M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.86B | -3.66% | 456,206 | 156.04M |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.85B | -8.80% | 4,859,957 | - |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.80B | 2.66% | 703,626 | 4.58B |
| 224 | VRDN | Viridian Therapeutics, Inc. | 2.75B | -0.08% | 259,858 | 71.13M |
| 225 | PRVA | Privia Health Group, Inc. | 2.71B | 0.50% | 92,407 | 2.36B |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.71B | -2.25% | 286,448 | 36.77M |
| 227 | ATAI | AtaiBeckley Inc. | 2.71B | -1.02% | 4,977,806 | 4.47M |
| 228 | AXGN | Axogen, Inc. | 2.66B | -2.00% | 121,926 | 251.17M |
| 229 | SUPN | Supernus Pharmaceuticals, Inc. | 2.65B | -0.52% | 105,456 | 830.44M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | 1.83% | 335,103 | 3.37B |
| 231 | PHVS | Pharvaris N.V. | 2.58B | 1.46% | 149,623 | - |
| 232 | NEOG | Neogen Corporation | 2.58B | -0.96% | 211,474 | 870.40M |
| 233 | RGC | Regencell Bioscience Holdings Limited | 2.58B | -1.89% | 68,055 | - |
| 234 | PGEN | Precigen, Inc. | 2.56B | -0.69% | 876,850 | 85.72M |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | -0.04% | 454,637 | 717.00M |
| 236 | WGS | GeneDx Holdings Corp. | 2.54B | -2.32% | 168,807 | 454.43M |
| 237 | TRVI | Trevi Therapeutics, Inc. | 2.52B | -1.67% | 389,212 | - |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.51B | 3.14% | 185,674 | 1.10B |
| 239 | ATRC | AtriCure, Inc. | 2.50B | 0.27% | 72,762 | 569.62M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | 1.57% | 554,873 | 940.61M |
| 241 | CDNA | CareDx, Inc. | 2.48B | -1.50% | 177,772 | 458.09M |
| 242 | NKTR | Nektar Therapeutics | 2.48B | -2.01% | 151,481 | 54.59M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.48B | 6.43% | 833,574 | - |
| 244 | BHC | Bausch Health Companies Inc. | 2.44B | 1.40% | 439,757 | 10.85B |
| 245 | NUVB | Nuvation Bio Inc. | 2.41B | -1.01% | 991,867 | 169.90M |
| 246 | GRDN | Guardian Pharmacy Services, Inc. | 2.41B | 0.24% | 67,530 | 1.46B |
| 247 | UFPT | UFP Technologies, Inc. | 2.37B | -0.98% | 32,668 | 631.64M |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.36B | 2.16% | 82,633 | 20.00M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.35B | -3.34% | 356,555 | 52.06M |
| 250 | BFLY | Butterfly Network, Inc. | 2.35B | -7.75% | 2,636,790 | 112.14M |
| 251 | ALMR | Alamar Biosciences, Inc. | 2.33B | -1.90% | 37,681 | 100.42M |
| 252 | KOD | Kodiak Sciences Inc. | 2.32B | -3.37% | 174,475 | - |
| 253 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -0.21% | 94,884 | - |
| 254 | URGN | UroGen Pharma Ltd. | 2.25B | -1.64% | 254,150 | 188.73M |
| 255 | NBTX | Nanobiotix S.A. | 2.25B | -9.48% | 110,020 | 38.27M |
| 256 | COAG | Hemab Therapeutics Holdings, Inc. | 2.25B | -2.07% | 78,223 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 0.67% | 88,318 | 959.90M |
| 258 | ADUS | Addus HomeCare Corporation | 2.22B | 0.55% | 24,658 | 1.48B |
| 259 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -0.30% | 132,395 | 311.51M |
| 260 | VCEL | Vericel Corporation | 2.20B | 0.87% | 207,774 | 306.30M |
| 261 | CLOV | Clover Health Investments, Corp. | 2.20B | -0.12% | 736,508 | 2.48B |
| 262 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 0.92% | 690,469 | 3.64B |
| 263 | ADMA | ADMA Biologics, Inc. | 2.19B | -0.56% | 329,697 | 512.28M |
| 264 | MESO | Mesoblast Limited | 2.19B | -2.06% | 55,846 | 65.38M |
| 265 | HCM | HUTCHMED (China) Limited | 2.18B | -3.40% | 21,435 | 549.12M |
| 266 | KLRA | Kailera Therapeutics, Inc. | 2.17B | -2.45% | 101,785 | - |
| 267 | ESTA | Establishment Labs Holdings Inc. | 2.16B | -0.07% | 40,975 | 245.82M |
| 268 | GENB | Generate Biomedicines, Inc. | 2.15B | 3.78% | 613,686 | 26.48M |
| 269 | NEO | NeoGenomics, Inc. | 2.13B | -2.15% | 174,476 | 766.30M |
| 270 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.13B | -5.15% | 2,118,492 | 208.78M |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.09% | 79,399 | 1.95B |
| 272 | TRLV | Trulieve Cannabis Corp. | 2.11B | -1.44% | 491,960 | 1.14B |
| 273 | BHVN | Biohaven Ltd. | 2.09B | 0.07% | 320,034 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.08B | 0.06% | 97,130 | 27.59M |
| 275 | XNCR | Xencor, Inc. | 2.08B | 0.79% | 161,110 | 104.97M |
| 276 | ZBIO | Zenas BioPharma, Inc. | 2.06B | -1.95% | 91,873 | 1.00M |
| 277 | PVLA | Palvella Therapeutics, Inc. | 2.03B | -1.05% | 126,186 | - |
| 278 | ASTH | Astrana Health, Inc. | 2.01B | -0.25% | 51,848 | 3.84B |
| 279 | ZYME | Zymeworks Inc. | 1.99B | -2.20% | 290,581 | 37.13M |
| 280 | PRGO | Perrigo Company plc | 1.96B | -0.77% | 314,021 | 4.14B |
| 281 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -0.68% | 184,891 | 98.34M |
| 282 | PGNY | Progyny, Inc. | 1.96B | -0.35% | 178,403 | 1.31B |
| 283 | NVCR | NovoCure Limited | 1.96B | -1.81% | 358,578 | 699.19M |
| 284 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -1.64% | 253,710 | 5.49M |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.95B | -1.81% | 309,191 | 1.97B |
| 286 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.02% | 910,490 | - |
| 287 | KARD | Kardigan, Inc. | 1.93B | -1.64% | 61,354 | - |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.92B | 0.81% | 90,254 | - |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.89B | -0.52% | 53,002 | 1.13B |
| 290 | GHRS | GH Research PLC | 1.89B | -2.84% | 41,285 | - |
| 291 | ETON | Eton Pharmaceuticals, Inc. | 1.89B | 4.14% | 345,680 | 105.60M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.89B | 0.61% | 29,400 | 481.07M |
| 293 | IMCR | Immunocore Holdings plc | 1.87B | -1.55% | 146,496 | 430.78M |
| 294 | SGRY | Surgery Partners, Inc. | 1.87B | -0.96% | 494,288 | 3.37B |
| 295 | CMPS | COMPASS Pathways plc | 1.86B | 0.83% | 727,442 | - |
| 296 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -0.72% | 47,454 | 262.43M |
| 297 | SEPN | Septerna, Inc. | 1.86B | -0.63% | 98,594 | 98.88M |
| 298 | PSNL | Personalis, Inc. | 1.84B | -6.37% | 2,131,543 | 69.67M |
| 299 | ALVO | Alvotech | 1.83B | 16.03% | 985,747 | 494.61M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.81B | -0.20% | 234,243 | 106.69M |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.78B | -1.23% | 49,965 | 898.74M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.33% | 12,164 | - |
| 303 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -6.86% | 7,814,087 | 54.86M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.74B | -3.12% | 1,203,853 | 59.51M |
| 305 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -0.97% | 397,104 | 252.25M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.73B | -1.20% | 207,992 | 2.68B |
| 307 | ANAB | AnaptysBio, Inc. | 1.72B | 0.38% | 53,278 | 232.39M |
| 308 | VIR | Vir Biotechnology, Inc. | 1.66B | 0.10% | 257,840 | 303.23M |
| 309 | AVLN | Avalyn Pharma Inc. | 1.65B | -2.97% | 43,657 | - |
| 310 | AGL | agilon health, inc. | 1.63B | 0.43% | 45,047 | 5.92B |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.62B | -0.82% | 49,804 | 20.00M |
| 312 | OMCL | Omnicell, Inc. | 1.61B | -1.05% | 52,297 | 1.25B |
| 313 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -0.89% | 61,554 | 978.38M |
| 314 | KMTS | Kestra Medical Technologies, Ltd. | 1.60B | 0.87% | 39,958 | 95.13M |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.58B | 1.05% | 73,631 | 1.86B |
| 316 | XERS | Xeris Biopharma Holdings, Inc. | 1.58B | -0.57% | 203,205 | 335.41M |
| 317 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 2.32% | 281,739 | - |
| 318 | ARDT | Ardent Health, Inc. | 1.57B | 1.59% | 81,352 | 6.41B |
| 319 | TNDM | Tandem Diabetes Care, Inc. | 1.57B | 1.03% | 345,395 | 1.04B |
| 320 | CNMD | CONMED Corporation | 1.56B | 2.17% | 114,802 | 1.37B |
| 321 | AAPG | Ascentage Pharma Group International | 1.56B | -0.50% | 1,455 | 94.61M |
| 322 | LBRX | LB Pharmaceuticals Inc | 1.56B | 1.24% | 83,939 | - |
| 323 | TYRA | Tyra Biosciences, Inc. | 1.55B | -0.08% | 81,547 | - |
| 324 | BCAX | Bicara Therapeutics Inc. | 1.55B | -2.13% | 284,536 | - |
| 325 | INNV | InnovAge Holding Corp. | 1.52B | 2.37% | 30,100 | 949.17M |
| 326 | INVA | Innoviva, Inc. | 1.52B | -0.05% | 94,737 | 440.00M |
| 327 | ABSI | Absci Corporation | 1.52B | -7.54% | 978,817 | 1.56M |
| 328 | ENOV | Enovis Corporation | 1.51B | 0.35% | 88,190 | 2.30B |
| 329 | OMDA | Omada Health, Inc. | 1.50B | 2.51% | 346,217 | 309.76M |
| 330 | SLBT | SL Science Holding Limited | 1.49B | -1.29% | 30,697 | 3.27M |
| 331 | FRNM | Freenome, Inc. | 1.48B | 0.07% | 128,819 | 35.41M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.47B | 0.69% | 282,031 | 815.05M |
| 333 | HROW | Harrow, Inc. | 1.47B | -4.03% | 170,667 | 275.59M |
| 334 | APMD | Apnimed, Inc. | 1.46B | -6.04% | 90,681 | 120.15M |
| 335 | PAHC | Phibro Animal Health Corporation | 1.46B | -0.95% | 21,268 | 1.50B |
| 336 | AZTA | Azenta, Inc. | 1.45B | -11.39% | 656,867 | 613.81M |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | -2.25% | 276,519 | - |
| 338 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -5.93% | 171,070 | 1.30M |
| 339 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | 1.03% | 8,260 | - |
| 340 | SDGR | Schrödinger, Inc. | 1.42B | -3.45% | 237,646 | 259.04M |
| 341 | NVAX | Novavax, Inc. | 1.42B | -3.80% | 2,425,635 | 413.80M |
| 342 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | 1.66% | 143,429 | - |
| 343 | SVRA | Savara Inc. | 1.40B | -1.61% | 351,638 | - |
| 344 | REPL | Replimune Group, Inc. | 1.39B | -0.27% | 364,649 | - |
| 345 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -3.50% | 48,700 | - |
| 346 | OMER | Omeros Corporation | 1.38B | -0.73% | 437,146 | 38.42M |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.38B | 2.77% | 426,737 | - |
| 348 | MGTX | MeiraGTx Holdings plc | 1.38B | 0.14% | 190,155 | 397.50M |
| 349 | PNTG | The Pennant Group, Inc. | 1.37B | 0.95% | 35,087 | 1.10B |
| 350 | AORT | Artivion, Inc. | 1.36B | -0.46% | 99,720 | 471.47M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.35B | -1.94% | 237,885 | - |
| 352 | VOR | Vor Biopharma Inc. | 1.34B | -2.97% | 191,427 | - |
| 353 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.25% | 51,204 | 3.43B |
| 354 | AKTS | Aktis Oncology, Inc. | 1.33B | -0.31% | 89,048 | 10.06M |
| 355 | ODTX | Odyssey Therapeutics, Inc. | 1.32B | 4.55% | 66,805 | 99.00K |
| 356 | MNKD | MannKind Corporation | 1.32B | -1.45% | 1,372,846 | 393.63M |
| 357 | JBIO | Jade Biosciences, Inc. | 1.31B | -3.66% | 125,461 | - |
| 358 | MLTX | MoonLake Immunotherapeutics | 1.30B | -2.89% | 287,228 | - |
| 359 | NUTX | Nutex Health Inc. | 1.29B | 1.30% | 94,177 | 846.72M |
| 360 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -0.99% | 58,240 | 1.65B |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.28B | -1.73% | 19,495 | - |
| 362 | CERT | Certara, Inc. | 1.26B | -2.02% | 309,611 | 421.75M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.23B | -1.11% | 202,092 | 337.34M |
| 364 | CRON | Cronos Group Inc. | 1.23B | 0.60% | 365,280 | 179.09M |
| 365 | BVS | Bioventus Inc. | 1.21B | 0.07% | 71,876 | 581.85M |
| 366 | GDRX | GoodRx Holdings, Inc. | 1.19B | 1.30% | 137,233 | 785.23M |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.18B | -0.89% | 33,896 | 1.04B |
| 368 | IMTX | Immatics N.V. | 1.18B | -3.19% | 142,298 | 47.65M |
| 369 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -3.04% | 116,062 | - |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.03% | 38,383 | 804.27M |
| 371 | GLUE | Monte Rosa Therapeutics, Inc. | 1.16B | -4.76% | 633,940 | 28.73M |
| 372 | STAA | STAAR Surgical Company | 1.16B | 0.04% | 85,320 | 339.59M |
| 373 | TDOC | Teladoc Health, Inc. | 1.15B | -0.94% | 555,015 | 2.49B |
| 374 | SANA | Sana Biotechnology, Inc. | 1.14B | -2.81% | 709,226 | - |
| 375 | IRMD | IRADIMED CORPORATION | 1.13B | 0.16% | 10,142 | 86.34M |
| 376 | JANX | Janux Therapeutics, Inc. | 1.12B | 5.46% | 254,615 | 24.00M |
| 377 | OPK | OPKO Health, Inc. | 1.11B | 0.68% | 706,466 | 587.90M |
| 378 | KURA | Kura Oncology, Inc. | 1.11B | 4.88% | 593,249 | 77.23M |
| 379 | IVA | Inventiva S.A. | 1.11B | -1.28% | 227,104 | 7.94M |
| 380 | GMRS | GMR Solutions Inc. | 1.08B | 3.23% | 99,498 | 5.88B |
| 381 | CSTL | Castle Biosciences, Inc. | 1.05B | 0.60% | 45,312 | 357.28M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -2.04% | 207,439 | 59.00K |
| 383 | WVE | Wave Life Sciences, Inc. | 1.03B | -1.04% | 639,745 | 65.37M |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.03B | - | 6,308,623 | 181.72M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.65% | 499,171 | 41.47M |
| 386 | PCRX | Pacira BioSciences, Inc. | 997.74M | 1.46% | 65,378 | 746.16M |
| 387 | QDEL | QuidelOrtho Corporation | 987.49M | -2.31% | 159,031 | 2.67B |
| 388 | SLDB | Solid Biosciences Inc. | 984.33M | -1.29% | 510,162 | - |
| 389 | CADL | Candel Therapeutics, Inc. | 977.91M | -2.67% | 305,054 | - |
| 390 | IMMX | Immix Biopharma, Inc. | 959.34M | -1.83% | 343,377 | - |
| 391 | ANNX | Annexon, Inc. | 957.37M | -0.39% | 1,179,502 | - |
| 392 | GERN | Geron Corporation | 954.07M | -2.30% | 4,762,891 | 204.56M |
| 393 | DSGN | Design Therapeutics, Inc. | 950.62M | 1.33% | 103,384 | - |
| 394 | GLAS | Glass House Brands Inc. | 946.19M | 2.55% | 67,670 | 176.98M |
| 395 | ARDX | Ardelyx, Inc. | 943.17M | -2.70% | 1,514,082 | 450.89M |
| 396 | HELP | Cybin Inc. | 934.44M | 1.59% | 438,414 | - |
| 397 | CLYM | Climb Bio, Inc. | 931.04M | -6.19% | 451,711 | - |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 923.97M | -1.22% | 205,429 | - |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 923.92M | 0.56% | 32,329 | 730.02M |
| 400 | ACRS | Aclaris Therapeutics, Inc. | 922.20M | -2.26% | 313,449 | 8.22M |
| 401 | CBLL | CeriBell, Inc. | 916.09M | -1.36% | 90,922 | 101.96M |
| 402 | SIBN | SI-BONE, Inc. | 895.03M | 0.05% | 69,730 | 213.60M |
| 403 | COLL | Collegium Pharmaceutical, Inc. | 890.88M | 0.94% | 167,918 | 808.21M |
| 404 | ANL | Adlai Nortye Ltd. | 884.18M | 0.22% | 31,863 | 18.06M |
| 405 | TBPH | Theravance Biopharma, Inc. | 882.10M | -0.12% | 59,187 | 104.31M |
| 406 | BBNX | Beta Bionics, Inc. | 881.80M | 2.89% | 69,316 | 119.01M |
| 407 | SGP | SpyGlass Pharma, Inc. | 881.02M | -0.64% | 12,039 | - |
| 408 | INMD | InMode Ltd. | 869.68M | 0.46% | 122,526 | 374.63M |
| 409 | DBVT | DBV Technologies S.A. | 862.94M | -1.92% | 92,724 | 5.04M |
| 410 | AVR | Anteris Technologies Global Corp. | 861.53M | -1.56% | 180,589 | 2.24M |
| 411 | ATTO | Attovia Therapeutics, Inc. | 859.93M | -3.92% | 19,624 | 1.35M |
| 412 | HSTM | HealthStream, Inc. | 853.51M | 1.11% | 25,425 | 321.12M |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 852.55M | -0.54% | 85,054 | 276.79M |
| 414 | PHAR | Pharming Group N.V. | 839.49M | -2.11% | 14,715 | 366.48M |
| 415 | FTH | Faeth Therapeutics, Inc. | 830.12M | 0.39% | 33,501 | - |
| 416 | AHG | Akso Health Group | 816.01M | 2.45% | 616 | 13.83M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 810.99M | -7.26% | 360,682 | 92.01M |
| 418 | ACHV | Achieve Life Sciences, Inc. | 809.84M | -1.50% | 265,099 | - |
| 419 | OBX | Obsidian Therapeutics, Inc. | 808.47M | -6.23% | 77,586 | - |
| 420 | OCS | Oculis Holding AG | 806.22M | -0.19% | 37,918 | 1.45M |
| 421 | AURA | Aura Biosciences, Inc. | 802.68M | -0.77% | 237,626 | - |
| 422 | SLN | Silence Therapeutics plc | 796.57M | -0.30% | 195,836 | 615.00K |
| 423 | NGNE | Neurogene Inc. | 792.45M | 2.51% | 41,401 | 925.00K |
| 424 | STTK | Shattuck Labs, Inc. | 780.83M | 3.32% | 514,634 | 1.00M |
| 425 | VREX | Varex Imaging Corporation | 780.58M | 0.05% | 81,918 | 865.00M |
| 426 | DRUG | Bright Minds Biosciences Inc. | 774.85M | 0.68% | 17,118 | - |
| 427 | NVCT | Nuvectis Pharma, Inc. | 772.51M | 0.64% | 89,063 | - |
| 428 | AHCO | AdaptHealth Corp. | 752.43M | 0.18% | 330,566 | 3.36B |
| 429 | PHR | Phreesia, Inc. | 738.96M | -1.36% | 132,140 | 495.59M |
| 430 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 2.44% | 565,061 | 18.30M |
| 431 | CBIO | Crescent Biopharma, Inc. | 731.47M | -0.35% | 12,537 | 11.88M |
| 432 | MNPR | Monopar Therapeutics Inc. | 731.43M | 1.16% | 95,127 | - |
| 433 | SOPH | SOPHiA GENETICS SA | 731.25M | -0.69% | 262,809 | 86.17M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 727.98M | - | 63,682 | - |
| 435 | GYRE | Gyre Therapeutics, Inc. | 727.39M | -0.72% | 14,599 | 109.82M |
| 436 | ASMB | Assembly Biosciences, Inc. | 715.88M | 2.27% | 92,681 | 74.85M |
| 437 | SCTX | Scribe Therapeutics Inc. | 714.96M | 11.05% | 183,199 | 36.28M |
| 438 | ALLO | Allogene Therapeutics, Inc. | 709.98M | -1.67% | 1,202,730 | 4.64M |
| 439 | ZVRA | Zevra Therapeutics, Inc. | 707.26M | 0.34% | 167,138 | 136.07M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 701.82M | -4.60% | 77,103 | - |
| 441 | SSII | SS Innovations International, Inc. | 701.35M | -2.37% | 26,308 | 52.40M |
| 442 | EVO | Evotec SE | 696.39M | -1.55% | 9,260 | 819.47M |
| 443 | PHAT | Phathom Pharmaceuticals, Inc. | 694.22M | -1.47% | 212,709 | 239.66M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 692.36M | -2.33% | 350,026 | 389.32M |
| 445 | PRLD | Prelude Therapeutics Incorporated | 685.95M | 0.45% | 194,837 | 22.42M |
| 446 | KIDS | OrthoPediatrics Corp. | 677.55M | 1.17% | 27,327 | 252.72M |
| 447 | VALN | Valneva SE | 656.66M | -3.52% | 9,990 | 163.30M |
| 448 | CRMD | CorMedix Inc. | 654.73M | 2.44% | 282,390 | 462.25M |
| 449 | STLN | Starling Oncology, Inc. | 648.19M | -1.62% | 356,150 | 587.24M |
| 450 | ANGO | AngioDynamics, Inc. | 645.61M | -0.83% | 21,368 | 320.17M |
| 451 | CTEV | Claritev Corporation | 640.78M | 1.45% | 13,995 | 994.67M |
| 452 | AGMB | AgomAb Therapeutics NV | 640.72M | -1.81% | 20,492 | - |
| 453 | OABI | OmniAb, Inc. | 638.26M | 1.39% | 354,455 | 38.46M |
| 454 | MDXG | MiMedx Group, Inc. | 634.06M | 0.46% | 135,322 | 355.17M |
| 455 | SGMT | Sagimet Biosciences Inc. | 634.02M | -0.49% | 311,475 | - |
| 456 | CTNM | Contineum Therapeutics, Inc. | 632.22M | -2.24% | 61,963 | - |
| 457 | TLRY | Tilray Brands, Inc. | 631.96M | -3.72% | 1,376,266 | 915.45M |
| 458 | AUTL | Autolus Therapeutics plc | 630.81M | -1.66% | 429,490 | 117.39M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 624.24M | 1.18% | 99,551 | - |
| 460 | VSTM | Verastem, Inc. | 621.27M | -0.44% | 179,883 | 87.53M |
| 461 | ZURA | Zura Bio Limited | 619.06M | 10.43% | 3,857,516 | - |
| 462 | ARVN | Arvinas, Inc. | 606.78M | -0.91% | 114,001 | 316.70M |
| 463 | BWAY | BrainsWay Ltd. | 605.12M | -3.05% | 38,293 | 60.70M |
| 464 | ALT | Altimmune, Inc. | 603.98M | -0.16% | 1,089,263 | 31.00K |
| 465 | DCTH | Delcath Systems, Inc. | 591.27M | -0.58% | 61,981 | 95.42M |
| 466 | AQST | Aquestive Therapeutics, Inc. | 584.88M | - | 542,931 | 54.09M |
| 467 | WEAV | Weave Communications, Inc. | 584.39M | 0.21% | 927,270 | 257.79M |
| 468 | PRME | Prime Medicine, Inc. | 578.19M | -4.13% | 857,122 | 4.07M |
| 469 | ENTX | Entera Bio Ltd. | 576.56M | 3.10% | 74,202 | 42.00K |
| 470 | CTKB | Cytek Biosciences, Inc. | 574.53M | -8.11% | 228,331 | 206.71M |
| 471 | EOLS | Evolus, Inc. | 557.14M | 0.54% | 102,467 | 316.49M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 552.46M | 3.39% | 90,831 | 251.00K |
| 473 | CERS | Cerus Corporation | 550.16M | -2.85% | 353,875 | 221.55M |
| 474 | RGNX | REGENXBIO Inc. | 543.95M | -23.13% | 1,887,664 | 174.48M |
| 475 | SRTA | Strata Critical Medical, Inc. | 537.44M | -2.64% | 225,570 | 255.98M |
| 476 | FLGT | Fulgent Genetics, Inc. | 535.72M | -2.16% | 35,095 | 323.93M |
| 477 | OVID | Ovid Therapeutics Inc. | 533.16M | -2.50% | 145,882 | 1.58M |
| 478 | TCMD | Tactile Systems Technology, Inc. | 532.90M | -1.24% | 41,468 | 350.31M |
| 479 | CABA | Cabaletta Bio, Inc. | 528.98M | -0.32% | 1,033,371 | - |
| 480 | EVH | Evolent Health, Inc. | 528.55M | -1.37% | 582,095 | 2.10B |
| 481 | SPRY | ARS Pharmaceuticals, Inc. | 527.07M | -3.72% | 602,903 | 116.93M |
| 482 | MPLT | MapLight Therapeutics, Inc. | 524.07M | 0.80% | 172,974 | - |
| 483 | RZLT | Rezolute, Inc. | 521.29M | -1.96% | 331,061 | - |
| 484 | SENS | Senseonics Holdings, Inc. | 513.94M | 0.10% | 301,214 | 48.55M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 505.26M | -2.97% | 169,123 | - |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | BLSM | BlossomHill Therapeutics, Inc. | 494.13M | -1.56% | 10,361 | - |
| 488 | QTTB | Q32 Bio Inc. | 491.20M | 3.32% | 179,943 | 53.74M |
| 489 | NRC | NRC Health | 488.40M | -0.50% | 14,123 | 140.00M |
| 490 | NPCE | NeuroPace, Inc. | 485.35M | 0.78% | 19,840 | 106.99M |
| 491 | EVMN | Evommune, Inc. | 483.41M | -4.99% | 65,537 | 10.00M |
| 492 | PROK | ProKidney Corp. | 482.20M | -0.93% | 425,471 | 818.00K |
| 493 | CCCC | C4 Therapeutics, Inc. | 478.57M | -2.75% | 650,565 | 35.04M |
| 494 | RLMD | Relmada Therapeutics, Inc. | 478.41M | -3.13% | 245,944 | - |
| 495 | PRTA | Prothena Corporation plc | 475.38M | -2.01% | 64,837 | 54.53M |
| 496 | PBYI | Puma Biotechnology, Inc. | 472.32M | -0.97% | 46,808 | 231.24M |
| 497 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | -5.95% | 261,077 | 132.42M |
| 498 | EDIT | Editas Medicine, Inc. | 468.42M | -1.93% | 484,374 | 47.01M |
| 499 | KMDA | Kamada Ltd. | 465.10M | 3.76% | 127,291 | 191.85M |
| 500 | OCGN | Ocugen, Inc. | 464.58M | -1.44% | 902,192 | 4.58M |